Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M125,421Revenue $M34,858Net Margin (%)12.0Z-Score2.2
Enterprise Value $M148,166EPS $0.9Operating Margin %15.6F-Score5
P/E(ttm))27.2Cash Flow Per Share $0Pre-tax Margin (%)12.9Higher ROA y-yN
Price/Book19.310-y EBITDA Growth Rate %0.5Quick Ratio0.8Cash flow > EarningsY
Price/Sales3.35-y EBITDA Growth Rate %-5.1Current Ratio1.1Lower Leverage y-yN
Price/Cash Flow0y-y EBITDA Growth Rate %-43.6ROA % (ttm)6.8Higher Current Ratio y-yN
Dividend Yield %5.5Insider Buy (3m)0ROE % (ttm)47.5Less Shares Outstanding y-yY
Payout Ratio %141Shares Outstanding M5,355ROI % (ttm)14.0Gross Margin Increase y-yY

Gurus Latest Trades with GLAXF

Number of guru portfolios checked: 84. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found!

GLAXF is held by these Gurus:

Premium Most recent portfolio changes are included for Premium Members only!


GLAXF: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
GLAXOSMITHKLINE PLCFormer 10% Owner 2015-02-23Sell503,150$228.05view
GLAXOSMITHKLINE PLC10% Owner 2014-12-18Sell50,000$21.1412.44view
GLAXOSMITHKLINE PLCFormer 10% Owner (1) 2014-10-27Sell11,315,825$5.29349.34view
GLAXOSMITHKLINE PLC10% Owner 2014-04-01Buy103,762$1298.08view
GLAXOSMITHKLINE PLCFormer 10% Owner 2014-02-19Buy35,000$1469.79view
GLAXOSMITHKLINE PLCFormer 10% Shareholder 2014-02-10Buy143,773$1298.08view

Press Releases about GLAXF :

    Quarterly/Annual Reports about GLAXF:

      News about GLAXF:

      Articles On GuruFocus.com
      British Stock Picks From Gurus During Q4 Mar 24 2015 
      Pfizer In The Process Of Making Path Breaking Vaccine Mar 18 2015 
      Bestinfond Adds More Than a Dozen Foreign Stocks to Portfolio Mar 06 2015 
      Causeway International Value Fund Adds 2 New Stocks Mar 03 2015 
      Novartis Gets FTC Nod To Buyout Glaxo Smithkline’s Cancer Drugs Feb 25 2015 
      Dodge & Cox 2014 Equity Year in Review Feb 19 2015 
      Bestinfond's Top 5 New Buys During Q4 Feb 03 2015 
      Can GlaxoSmithKline Continue Striving in the Face of World Challenges? Jan 30 2015 
      Tumor Drug Takes The Focus At OncoMed Pharmaceuticals Jan 29 2015 
      Gilead Sciences Still has More Upside Jan 22 2015 

      More From Other Websites
      China pulls back tax breaks for foreign companies Mar 27 2015
      Two experimental Ebola vaccines pass safety test in African trial Mar 26 2015
      Two experimental Ebola vaccines pass safety test in African trial Mar 26 2015
      Actavis takes 'specialty pharma' route to health Mar 26 2015
      UK businesses lobby for better cycling infrastructure Mar 19 2015
      FDA panel backs Glaxo asthma drug for adults, not adolescents Mar 19 2015
      FDA panel backs Glaxo asthma drug for adults, not adolescents Mar 19 2015
      GSK sale of Aspen stake a 'credit positive' move, says Moody's Mar 18 2015
      FDA staff finds no new safety problems with Glaxo's asthma drug Mar 17 2015
      FDA staff finds no new safety problems with Glaxo's asthma drug Mar 17 2015
      Dementia research boosted by $100m venture capital fund Mar 16 2015
      Malin aims to raise ?300m with IPO Mar 15 2015
      FTSE 250 movers: Afren plummets on looming dilution, Diploma higher on Kubo deal Mar 13 2015
      GSK raises $853 mln by halving stake in S.African drugmaker Mar 13 2015
      Glaxo completes part sale of Aspen stake Mar 13 2015
      Johnson & Johnson sues Glaxo over allergy ads as spring nears Mar 12 2015
      'Boohoo is crying out for an activist investor' Mar 12 2015
      GSK to pocket $890 mln by halving stake in S.African drugmaker Mar 12 2015
      GSK launches $890mln placement in Aspen Pharmacare - source Mar 12 2015
      Drugmaker GSK to steer Asian business from new Singapore HQ Mar 11 2015

      Add Notes, Comments

      If you want to ask a question, or report a bug, please create a support ticket.

      User Comments

      No comment yet
      Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
      GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
      Free 7-day Trial
      FEEDBACK